Oppenheimer Holdings, Inc. set a $24.00 target price on K2M Group Holdings, Inc. (NASDAQ:KTWO) in a report released on Wednesday. The brokerage currently has a buy rating on the medical device company’s stock.

Several other equities analysts have also commented on KTWO. JMP Securities reaffirmed an outperform rating and set a $30.00 price target (up previously from $27.00) on shares of K2M Group Holdings in a research report on Wednesday, June 28th. Cowen and Company reaffirmed a buy rating and set a $26.00 price target on shares of K2M Group Holdings in a research report on Wednesday, July 19th. BidaskClub raised shares of K2M Group Holdings from a hold rating to a buy rating in a research report on Wednesday, July 19th. Royal Bank Of Canada reaffirmed a buy rating and set a $26.00 price target on shares of K2M Group Holdings in a research report on Thursday, July 20th. Finally, Needham & Company LLC reaffirmed a buy rating on shares of K2M Group Holdings in a research report on Wednesday, August 2nd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. K2M Group Holdings presently has an average rating of Buy and a consensus price target of $25.10.

K2M Group Holdings (NASDAQ KTWO) traded down 1.20% during trading on Wednesday, hitting $19.75. 448,587 shares of the company were exchanged. The company has a 50-day moving average of $21.27 and a 200-day moving average of $22.47. K2M Group Holdings has a 12 month low of $16.32 and a 12 month high of $25.99. The company’s market capitalization is $854.54 million.

K2M Group Holdings (NASDAQ:KTWO) last issued its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.01. K2M Group Holdings had a negative net margin of 16.21% and a negative return on equity of 15.45%. The firm had revenue of $65.70 million during the quarter, compared to analyst estimates of $66.26 million. During the same quarter in the prior year, the business posted ($0.27) earnings per share. K2M Group Holdings’s revenue for the quarter was up 11.0% compared to the same quarter last year. Analysts forecast that K2M Group Holdings will post ($0.84) EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/k2m-group-holdings-inc-ktwo-given-a-24-00-price-target-by-oppenheimer-holdings-inc-analysts/1641883.html.

In other news, CFO Gregory S. Cole sold 39,357 shares of the stock in a transaction on Friday, August 11th. The shares were sold at an average price of $23.37, for a total value of $919,773.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Gregory S. Cole sold 2,350 shares of the stock in a transaction on Tuesday, August 15th. The stock was sold at an average price of $24.08, for a total transaction of $56,588.00. Following the completion of the sale, the chief financial officer now directly owns 55,158 shares of the company’s stock, valued at approximately $1,328,204.64. The disclosure for this sale can be found here. Insiders sold 44,129 shares of company stock valued at $1,033,644 in the last three months. Company insiders own 5.80% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in the company. Paulson & CO. Inc. increased its position in shares of K2M Group Holdings by 13.6% in the second quarter. Paulson & CO. Inc. now owns 109,600 shares of the medical device company’s stock worth $2,670,000 after acquiring an additional 13,100 shares in the last quarter. California State Teachers Retirement System boosted its stake in shares of K2M Group Holdings by 41.8% in the second quarter. California State Teachers Retirement System now owns 71,871 shares of the medical device company’s stock valued at $1,751,000 after purchasing an additional 21,200 shares during the period. The Manufacturers Life Insurance Company boosted its stake in shares of K2M Group Holdings by 51.0% in the second quarter. The Manufacturers Life Insurance Company now owns 31,807 shares of the medical device company’s stock valued at $774,000 after purchasing an additional 10,738 shares during the period. State Street Corp boosted its stake in shares of K2M Group Holdings by 39.8% in the second quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock valued at $17,378,000 after purchasing an additional 203,067 shares during the period. Finally, Macquarie Group Ltd. boosted its stake in shares of K2M Group Holdings by 0.3% in the second quarter. Macquarie Group Ltd. now owns 200,656 shares of the medical device company’s stock valued at $4,888,000 after purchasing an additional 581 shares during the period. 97.77% of the stock is owned by institutional investors.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.